MyFinsight
Home
Blog
About
Back
Cash Flow
Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. (ELOX)
source: myfinsight.com
Proceeds from the june
2026 public...
$60,295K
Exercise of pre-funded
warrants
$91K
Net cash provided by
(used in) financing...
$60,386K
Increase in cash, cash
equivalents and restricted...
$55,597K
Canceled cashflow
$4,789K
Prepaid expenses and
other current assets
-$712K
Stock-based compensation
$95K
Change in fair value of
warrant liabilities
$62K
Amortization of debt discount
$8K
Net cash (used in)
provided by operating...
-$4,789K
Canceled cashflow
$877K
Net loss
-$4,502K
Accounts payable
-$782K
Accrued expenses
-$382K
Back